Leading cannabis producer Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) has released a cannabinol (CBN) oil to help its patients sleep.
On Tuesday, the firm announced the release of its Aphria CBN Night oil which is supposed to help improve the duration and quality of sleep. The 50-milligram bottle contains 30 milligrams of CBN and 10 milligrams of THC per millilitre and is composed of a broad-spectrum cannabis distillate.
The company says the oil is designed to be used in conjunction with a nighttime routine and it’s available on the company’s Tilray Medical website.
Aphria CBN Night oil. The 50-milligram bottle contains 30 milligrams of CBN and 10 milligrams of THC per millilitre and is composed of a broad-spectrum cannabis distillate. Photo via Tilray
Tilray is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America.
The company was one of the first to become approved for producing medical cannabis in Canada and has one of the first GMP-certified cannabis production facilities in Europe, including Portugal and later Germany.
“Tilray Medical is committed to providing patients in Canada and around the globe with safe, high-quality cannabinoid-based medicine,” Tilray Canada President Blair Mac Neil said.
We are pleased to add a dedicated night oil to the Aphria medical portfolio and broaden our offering of effective medical cannabis products to patients with a wider range of needs.”
Read more: Tilray launches new CBD wellness brand sold via Amazon UK
Read more: Tilray Q3 revenue dips 2% to US$151.9M
